[Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
Folwaczny
C
C
Medizinische Klinik, Ludwig-Maximilians Universität München.
D000536:Aluminum Hydroxide / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005745:Gastric Acidity Determination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008276:Magnesium Hydroxide / Q000627:therapeutic use*; D008795:Metronidazole / Q000627:therapeutic use; D009853:Omeprazole / Q000627:therapeutic use; D012841:Simethicone / Q000627:therapeutic use*; D013276:Stomach Ulcer / Q000188:drug therapy*; D013752:Tetracycline / Q000627:therapeutic use
D000863:Antacids; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; C008570:aluminum hydroxide, magnesium hydroxide, simethicone drug combination; D008795:Metronidazole; D000536:Aluminum Hydroxide; D012841:Simethicone; D013752:Tetracycline; D009853:Omeprazole; D008276:Magnesium Hydroxide; D001729:Bismuth
Antibakterielle Therapie H. pylori--positiver Ulcera ventriculi ohne Säurehemmung.